Pfizer says earliest U.S. filing for COVID-19 vaccine would be late November
Published
Pfizer Inc said on Friday it could file in late November for U.S. authorization of the COVID-19 vaccine it is developing, suggesting that a vaccine could potentially be…
Full Article